FES - FES proto-oncogene, tyrosine kinase Gene

Also Known as FPS

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 2242

About FES

Cytogenetic location: 15q26.1 Genomic coordinates (GRCh38): 15:90,884,504-90,895,776 (from NCBI)

This gene has 17 transcripts (splice variants), 193 orthologues, 32 paralogues and is associated with 56 phenotypes. Broad expression in spleen (RPKM 39.1), bone marrow (RPKM 25.6) and 23 other tissues.

Summary

This gene encodes the human cellular counterpart of a feline sarcoma retrovirus protein with transforming capabilities. The gene product has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Its chromosomal location has linked it to a specific translocation event identified in patients with acute promyelocytic leukemia but it is also involved in normal hematopoiesis as well as growth factor and cytokine receptor signaling. Alternative splicing results in multiple variants encoding different isoforms.[provided by RefSeq, Jan 2009]

FES Products (4)

mRNA	Protein	Name
NM_001143783.1	NP_001137255.1	tyrosine-protein kinase Fes/Fps isoform 2
NM_001143784.1	NP_001137256.1	tyrosine-protein kinase Fes/Fps isoform 3
NM_001143785.2	NP_001137257.1	tyrosine-protein kinase Fes/Fps isoform 4
NM_002005.4	NP_001996.1	tyrosine-protein kinase Fes/Fps isoform 1

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables immunoglobulin receptor binding	IDA IDA: Inferred from direct assay	19001085	GOA
enables non-membrane spanning protein tyrosine kinase activity	IDA IDA: Inferred from direct assay	15485904	GOA
enables phosphatidylinositol binding	IDA IDA: Inferred from direct assay	19001085	GOA
enables protein binding	IPI IPI: Inferred from physical interaction	18046454	GOA
enables protein tyrosine kinase activity	IDA IDA: Inferred from direct assay	11509660	GOA

Biological Process GO Annotation	Evidence	References	Source
involved in cellular response to vitamin D	IMP IMP: Inferred from mutant phenotype	28389358	GOA
involved in peptidyl-tyrosine phosphorylation	IDA IDA: Inferred from direct assay	11509660	GOA
involved in positive regulation of microtubule polymerization	IMP IMP: Inferred from mutant phenotype	15485904	GOA
involved in positive regulation of monocyte differentiation	IMP IMP: Inferred from mutant phenotype	28389358	GOA
involved in positive regulation of myeloid cell differentiation	IMP IMP: Inferred from mutant phenotype	2656706	GOA
involved in positive regulation of neuron projection development	IMP IMP: Inferred from mutant phenotype	15302586	GOA
involved in protein autophosphorylation	IDA IDA: Inferred from direct assay	7687763	GOA
involved in regulation of cell adhesion	IMP IMP: Inferred from mutant phenotype	11509660	GOA
involved in regulation of cell differentiation	IMP IMP: Inferred from mutant phenotype	15302586	GOA
involved in regulation of cell motility	IMP IMP: Inferred from mutant phenotype	18046454	GOA
involved in regulation of cell population proliferation	IMP IMP: Inferred from mutant phenotype	11509660	GOA
involved in regulation of cell shape	IMP IMP: Inferred from mutant phenotype	11509660	GOA
involved in regulation of mast cell degranulation	IMP IMP: Inferred from mutant phenotype	19001085	GOA

Cellular Component GO Annotation	Evidence	References	Source
located in cytoplasm	IDA IDA: Inferred from direct assay	11339827	GOA
located in cytoplasmic side of plasma membrane	IDA IDA: Inferred from direct assay	18046454	GOA
colocalizes with cytoplasmic vesicle	IDA IDA: Inferred from direct assay	11339827	GOA
located in focal adhesion	IDA IDA: Inferred from direct assay	18046454	GOA
located in microtubule cytoskeleton	IDA IDA: Inferred from direct assay	15485904	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

FES Protein Structure

FCH

SH2

Pkinase_Tyr

0
200
400
600
822 a.a.

Protein Preferred Names	Protein Names
tyrosine-protein kinase Fes/Fps	Oncogene FES, feline sarcoma virus

FES Protein-protein interaction Information

Type	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	References
Intra	FES	P07332	EZR	Homo sapiens	P15311	Anti Bait CoIP	18046454
Intra	FES	P07332	EZR	Homo sapiens	P15311	Pull Down	18046454
Intra	FES	P07332	KIT	Homo sapiens	P10721	FPS	24728074
Intra	FES	P07332	DSP	Homo sapiens	P15924	Pull Down	32707033
Intra	FES	P07332	GAB1	Homo sapiens	Q13480	FPS	24728074
Intra	FES	P07332	AR	Homo sapiens	P10275	FPS	24728074
Intra	FES	P07332	TERF1	Homo sapiens	P54274	Pull Down	21044950

Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant FES Proteins

Cat. No.	Product Name	Accession	Purity
HY-P73050	FES Protein, Human (Active, sf9, His-GST)	P07332-1 (M1-R822)	≥ 80%, as determined by reducing SDS-PAGE.

FES Antibodies

Cat. No.	Product Name	Application	Reactivity
HY-P83075	FES Antibody (YA2820)	WB	Human
HY-P83075A	FES Antibody (YA2820)(PBS only)	WB	Human
HY-P85159	FES Antibody (YA4851)	WB, IHC-P, ICC/IF, ELISA	Human

Related Diseases

Diseases	Alias
Sarcoma	Connective And Soft Tissue Neoplasm Tumor Of Soft Tissue And Skeleton Sarcomas Sarcoma - Category
Myeloid Leukemia	Myeloid Leukaemia Leukaemia Myelogenous Leukemia Myelogenous Myeloid Granulocytic Leukaemia Myeloid Granulocytic Leukemia Non-Lymphocytic Leukemia Leukemia, Myeloid Granulocytic Leukaemia Myelogenous Leukaemia Myeloid Leukaemia, Unspecified, Without Mention Of Remission
Leukemia	Leukemias Leukaemia, Unspecified, Without Mention Of Remission Aleukemic Leukaemia Chronic Leukaemia Subacute Leukaemia Leukaemia Disorder Leukaemia Nos
Acute Promyelocytic Leukemia	Leukemia, Acute Promyelocytic Acute Myeloblastic Leukemia Type 3 Aml M3 APL Leukemia, Acute Promyelocytic, Somatic Aml With T(15 17)(Q22 Q12) (Pml/Raralpha) And Variants Apml Acute Myeloblastic Leukemia 3 Acute Myeloid Leukemia With T(15 17)(Q22 Q12) (Pml/Raralpha) And Variants Acute Myeloblastic Leukaemia Type 3 Acute Myeloid Leukaemia M3 Acute Myeloid Leukemia M3 Acute Promyelocytic Leukaemia M3 Anll Myeloid Leukemia, Acute, M3 Leukemia Promyelocytic Acute Leukemia, Promyelocytic, Acute Leukemia, Acute, Promyelocytic
Ewing Sarcoma Of Bone	Ewing'S Sarcoma Of Bone Bone Ewing Sarcoma Bone Ewing'S Sarcoma Bone Localized Ewing Sarcoma Bone Localized Ewing'S Sarcoma Ewing'S Sarcoma/Bone Peripheral Primitive Neuroectodermal Tumor Localized Skeletal Ewing'S Sarcoma Localized Bone Ewing Sarcoma
Myopathy, Centronuclear, 2	Myopathy, Centronuclear, Autosomal Recessive Autosomal Recessive Centronuclear Myopathy CNM2 Centronuclear Myopathy 2 Ar-Cnm Myotubular Myopathy, Autosomal Recessive Autosomal Recessive Myotubular Myopathy Centronuclear Myopathy Autosomal Recessive Myopathy, Centronuclear, Type 2
Melanoma	Malignant Melanoma Cutaneous Melanoma Naevocarcinoma Malignant Melanomas
Leukemia, Chronic Myeloid	Chronic Myeloid Leukemia Chronic Myelogenous Leukemia CML Chronic Granulocytic Leukemia Leukemia, Philadelphia Chromosome-Positive, Resistant To Imatinib Chronic Myeloid Leukaemia Chronic Granulocytic Leukaemia Chronic Myelogenous Leukaemia Myeloid Leukemia, Chronic Leukemia, Chronic Myelogenous Leukemia, Chronic Myeloid, Philadelphia Chromosome Positive, Somatic Cml - Chronic Myelogenous Leukemia Cgl Chronic Myelocytic Leukemia Leukemia, Chronic Myeloid, Atypical ACML Atypical Chronic Myeloid Leukemia Bcr-Abl1 Negative Myeloid Leukemia Chronic Leukemia, Myeloid, Chronic Leukemia, Myeloid, Chronic, Atypical, Bcr-Abl Negative Cml- [Chronic Myeloid Leukaemia] Cgl - [Chronic Granulocytic Leukaemia] Chronic Myelocytic Leukaemia
Prostate Cancer	Prostate Carcinoma Prostate Cancer, Familial Prostate Neoplasm Prostate Cancer, Somatic Prostate Cancer, Susceptibility To Prostatic Cancer Prostatic Neoplasms Hereditary Prostate Cancer Prostatic Neoplasm Cancer Of Prostate Carcinoma Of Prostate Familial Prostate Cancer Familial Prostate Carcinoma Malignant Tumor Of Prostate Malignant Neoplasm Of Prostate Prostate Cancer, Familial, Susceptibility To Malignant Tumor Of The Prostate Ngp - New Growth Of Prostate Tumor Of The Prostate Prostate Cancer, Hereditary Cancer Of The Prostate Malignant Neoplasm Of The Prostate Prostatic Carcinoma PC Prca Cancer, Prostate Malignant Prostatic Tumour Malignant Tumour Of Prostate Primary Prostate Cancer Primary Malignant Neoplasm Of Prostate Prostate Gland Cancer

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (10)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0988	Deferoxamine mesylate		99.86%	Unkown
HY-B1625	Deferoxamine		99.76%	Yes
HY-16168A	Degarelix		99.96%	Unkown
HY-107928	Iron dextran		/	Unkown
HY-B1306	4-Aminohippuric acid		99.84%	Unkown
HY-16564	Deferasirox (Fe3+ chelate)	Inhibitor	98.0%	Unkown
HY-108017	Ferric maltol		99.93%	Unkown
HY-16168	Degarelix acetate	Antagonist	99.67%	Unkown
HY-16168B	Degarelix acetate hydrate		/	Unkown
HY-17609C	Difelikefalin acetate	Agonist	/	Unkown

Clinical Phase

Bioactive Molecules (7)

Cat. No.	Product Name	Effect	Purity	Phase
HY-12040	Elesclomol		99.43%	Phase 3
HY-P1714	Apraglutide		99.90%	Phase 3
HY-105239	Selepressin	Agonist	98.17%	Phase 3
HY-105239A	Selepressin acetate	Agonist	98.04%	Phase 3
HY-P1714A	Apraglutide TFA		98.69%	Phase 3
HY-122844	Ifebemtinib	Inhibitor	99.86%	Phase 2
HY-P3516	Barusiban	Antagonist	/	Phase 2

Pre-clinical Phase

Bioactive Molecules (171)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-D1533	RhoNox-1		98.54%	Unkown
HY-W004544	o-Phenanthroline	Inhibitor	99.96%	Unkown
HY-D1913	Fe2Orange		98.2%	Unkown
HY-137805	Ferrozine		99.96%	Unkown
HY-N0928	Mimosine	Inducer	99.97%	Unkown
HY-128525	Enterobactin	Inhibitor	99.64%	Unkown
HY-W075707	FeTCPP chloride		95.0%	Unkown
HY-145157	Ferric nitrilotriacetate		98.0%	Unkown
HY-N10473	Pulcherriminic acid	Inhibitor	98.0%	Unkown
HY-D2295	Mito-FerroGreen		97.30%	Unkown
HY-D0221	2,4,6-Tri-2-pyridinyl-1,3,5-triazine		99.87%	Unkown
HY-Y1841	o-Phenanthroline monohydrate	Inhibitor	99.95%	Unkown
HY-126823	Phen Green SK diacetate (5/6-mixture)		92.99%	Unkown
HY-163897	PROTAC NCOA4 degrader-1	Inhibitor	99.75%	Unkown
HY-N10470	Bleomycin A5		99.81%	Unkown
HY-P3267A	Apo-Bovine Transferrin	Activator	95.2%	Unkown
HY-132989	Mal-Deferoxamine		95.0%	Unkown
HY-156418	KY386		99.86%	Unkown
HY-D0945	Xylene Cyanol FF		94.69%	Unkown
HY-107928B	Iron–Dextran(Fe 35-40% w/w)		/	Unkown
HY-W010323	2,5-Dihydroxy-1,4-benzoquinone	Inhibitor	99.95%	Unkown
HY-W015600	2-Acetamidophenol		99.73%	Unkown
HY-W075508	MIL-100(Fe)		≥98.0%	Unkown
HY-158739	Rhodamine dithenoyl hydrazide		98.00%	Unkown
HY-DY1030	RhoNox-1 (solution)		/	Unkown
HY-158779	Sulfane sulfur probe 4		97.3%	Unkown
HY-Y1422I	Lipase,Pseudomonas fluorescens (Immobilized)		/	Unkown
HY-D2339	H-FluNox		99.53%	Unkown
HY-W698249	Ferrous gluconate		99.25%	Unkown
HY-160238	Bacillibactin	Inhibitor	98.1%	Unkown
HY-Y0102	Thiosalicylic acid		99.28%	Unkown
HY-136300	PHD-1-IN-1	Inhibitor	99.21%	Unkown
HY-W019888	Iron(II) chloride		99.99%	Unkown
HY-W151629A	Ferrozine sodium hydrate		99.80%	Unkown
HY-145286	IMPDH2-IN-2		99.89%	Unkown
HY-178364	GPX4-IN-19		99.45%	Unkown
HY-B1250	Acedoben		99.68%	Unkown
HY-P2777	Ceruloplasmin		/	Unkown
HY-W067445	N-(4-Formylphenyl)acetamide		99.68%	Unkown
HY-B1159S	Nitroxoline-d4		99.7%	Unkown
HY-B1250A	Acedoben sodium		99.99%	Unkown
HY-N0046	Notoginsenoside Fe	Inhibitor	99.99%	Unkown
HY-W011816	1,2-Hexadecanediol		99.94%	Unkown
HY-W015600S	2-Acetamidophenol-d3		99.48%	Unkown
HY-W134005	Mg(Ⅱ)-EDTA disodium tetrahydrate		99.16%	Unkown
HY-W112939	Fe(III)(TDCPP) chloride		95.00%	Unkown
HY-155539	Cisd2 agonist 2	Agonist	99.17%	Unkown
HY-156776	HAPSBC		≥95.0%	Unkown
HY-W249602	MIL-88A(Fe)		/	Unkown
HY-N18050	Petrobactin		/	Unkown
HY-160414	TRX-COBI	Inhibitor	/	Unkown
HY-B1306S	4-Aminohippuric acid-d4		98.6%	Unkown
HY-D3116	RhoNox-4	Inhibitor	98.55%	Unkown
HY-W107177	5,10,15,20-tetrakis(p-chlorophenyl)porphyrin iron(III) chloride		95.00%	Unkown
HY-W112021	2,5-DMBQ		99.99%	Unkown
HY-W113011	5,10,15,20-Tetra(4-methylphenyl)-21H,23H-porphine iron(III) chloride		/	Unkown
HY-W124354	MIL-101-Fe		/	Unkown
HY-W718262	Dihydroaeruginoic acid		/	Unkown
HY-Y1422E	Lipase,Aspergillusniger (Immobilized)		/	Unkown
HY-N13871	Anguibactin	Inhibitor	/	Unkown
HY-125918	Bleomycin A5 hydrochloride		/	Unkown
HY-100332	CP 375		/	Unkown
HY-115832	Ap44mSe		/	Unkown
HY-117478	FE-999024	Inhibitor	/	Unkown
HY-117710B	AD-35	Inhibitor	/	Unkown
HY-12040S	Elesclomol-d2		/	Unkown
HY-133849	Aristoforin	Inhibitor	/	Unkown
HY-138185	Collismycin A	Inhibitor	/	Unkown
HY-143249	MtMetAP1-IN-1	Inhibitor	/	Unkown
HY-149151	Variegatic acid	Inhibitor	/	Unkown
HY-149418	BChE/HDAC6-IN-2	Inhibitor	/	Unkown
HY-155158	Anticancer agent 147	Inducer	/	Unkown
HY-157917	Nitro-PAPS disodium dihydrate		/	Unkown
HY-157926	Nitroso-PSAP		/	Unkown
HY-159943	ROS151	Inhibitor	/	Unkown
HY-16168AS	Degarelix-d7	Antagonist	/	Unkown
HY-16168AS1	Degarelix-d7 TFA		/	Unkown
HY-16168AS2	Degarelix-d7 TFA-1		/	Unkown
HY-162812	H3R antagonist 4	Inhibitor	/	Unkown
HY-162933	AChE-IN-77	Inhibitor	/	Unkown
HY-165381	ZMC2	Inducer	/	Unkown
HY-170433	DefNEtTrp	Inducer	/	Unkown
HY-172092	BG11	Inducer	/	Unkown
HY-174867	AY-4	Agonist	/	Unkown
HY-175698	Ferroptosis inducer-9		/	Unkown
HY-175852	Ferroptosis inducer-11		/	Unkown
HY-176212	Ferroptosis-IN-20	Inhibitor	/	Unkown
HY-17655	TBE56	Inhibitor	/	Unkown
HY-177506	FE100726	Agonist	/	Unkown
HY-177507	FE101120	Agonist	/	Unkown
HY-178370	Ferroptosis inducer-12	Inducer	96.32%	Unkown
HY-179003	mTOR/GLS1-IN-1		/	Unkown
HY-179016	Ferroptosis/apoptosis inducer-3		/	Unkown
HY-180114	NSS-18		/	Unkown
HY-181982	HJ03		/	Unkown
HY-182300	FE 999011		/	Unkown
HY-182578	Mimosinamine	Inhibitor	/	Unkown
HY-183618	DW-229	Degrader	/	Unkown
HY-183760	AChE/BChE-IN-37	Inhibitor	/	Unkown
HY-186106	3-Deoxyanguibactin		/	Unkown
HY-186239	Azophloxine-1,7-disulfonate disodium		/	Unkown
HY-D2204	SHP1-IN-1	Inhibitor	/	Unkown
HY-D2730	N14G-Fe	Inhibitor	/	Unkown
HY-D3377	HMRhoNox-M		/	Unkown
HY-DY1106	Ferrozine (solution)		/	Unkown
HY-E70311	1,3-specific lipase,Bacillus lanolin (Immobilized)		/	Unkown
HY-E70583	Recombinant Ten-Eleven Translocase		/	Unkown
HY-E70905	Taurine Dioxygenase, E. coli		/	Unkown
HY-E71077	(5R)-Carbapenem-3-carboxylate synthase		/	Unkown
HY-E71089	(R)-2-Methylmalate dehydratase		/	Unkown
HY-E71099	(R)-Dichlorprop dioxygenase 2-oxoglutarate		/	Unkown
HY-E71143	1,2-Dihydroxynaphthalene dioxygenase		/	Unkown
HY-E71221	α-D-Ribose 1-methylphosphonate 5-phosphate C-P-lyase		/	Unkown
HY-E71278	β-Carotene 15,15'-dioxygenase		/	Unkown
HY-E71279	β-Carotene 3-hydroxylase		/	Unkown
HY-E71332	γ-Butyrobetaine dioxygenase		/	Unkown
HY-E71337	γ-Glutamyl hercynylcysteine S-oxide synthase		/	Unkown
HY-E71402	2-(3-amino-3-carboxypropyl)Histidine synthase		/	Unkown
HY-E71453C	23S rRNA (adenine2503-C2)-Methyltransferase		/	Unkown
HY-E71453U	23S rRNA (uracil1939-C5)-Methyltransferase		/	Unkown
HY-N17362	Anhydroevoxine		/	Unkown
HY-P11424	Cyclo(GRGDSPA)	Inhibitor	/	Unkown
HY-P11504	Fmoc-Lys-Gly-Dopa-OH		/	Unkown
HY-RS04867	FES Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W004544S	o-Phenanthroline-d8	Inhibitor	/	Unkown
HY-W075620	NH2-MIL-88B(Fe)		/	Unkown
HY-W075622	NH2-MIL-53(Fe)		/	Unkown
HY-W075623	NH2-MIL-101(Fe)		/	Unkown
HY-W075625	MIL-88B(Fe)		/	Unkown
HY-W075630	Mil-53(Fe)		/	Unkown
HY-W249563	PCN-250(Fe2Co)		/	Unkown
HY-W249605	PCN-222		/	Unkown
HY-W414357	2-Aminophenanthrene		/	Unkown
HY-W698271	Ferrous lactate trihydrate		/	Unkown
HY-W747297	β-Selinene	Inhibitor	/	Unkown
HY-W747910A	S584 dihydrochloride		/	Unkown
HY-138075	Obafluorin	Inhibitor	99.9%	Unkown
HY-148340	24RBPyBC		/	Unkown
HY-153217	Arsonic acid		/	Unkown
HY-153512	PHD-1-IN-3	Inhibitor	/	Unkown
HY-17609S	Difelikefalin-d5	Agonist	/	Unkown
HY-179102	SARS-CoV-2 Mpro-IN-51	Inhibitor	/	Unkown
HY-180223	FXIa-IN-17	Inhibitor	/	Unkown
HY-184620	Fe3O4 nanoparticle		/	Unkown
HY-184625	PEI coated Fe3O4 nanoparticles		/	Unkown
HY-184627	Carboxylated dextran coated Fe3O4 nanoparticles		/	Unkown
HY-184629	Ultra small magnetic Fe3O4 nanoparticles		/	Unkown
HY-184630	PLL coated Fe3O4 nanoparticles		/	Unkown
HY-184631	Carboxymethyldextran modified Fe3O4 nanoparticles		/	Unkown
HY-184632	Fe3O4 nanorods		/	Unkown
HY-184633	Hollow mesoporous Fe3O4 nanoparticles		/	Unkown
HY-184634	OA Coated Fe3O4 Nanoparticles		/	Unkown
HY-184635	Monodisperse Fe3O4 microspheres		/	Unkown
HY-184636	PLL coated Fe2O3 nanoparticles		/	Unkown
HY-184637	DMSA Coated Fe2O3 Nanoparticles		/	Unkown
HY-184638	APTS Fe2O3 Nanoparticles		/	Unkown
HY-184639	Carboxylated magnetic microspheres (low non-specificity)		/	Unkown
HY-184640	Carboxylated magnetic microspheres		/	Unkown
HY-184643	Mn-Zn Ferrite Nanoparticles		/	Unkown
HY-184647	Citrate-modified ferric oxide nanoparticles		/	Unkown
HY-185401	ATSM		/	Unkown
HY-N14059	Halymecin B		/	Unkown
HY-N14060	Halymecin C		/	Unkown
HY-N15282	Broussoflavonol G		/	Unkown
HY-RS18447	Fes Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS24929	Fes Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W008952	Tributyltetradecyl phosphonium chloride		/	Unkown
HY-W009022	Diantipyrylmethane		98.98%	Unkown
HY-W094110	Iron(III) sulfate		/	Unkown
HY-W130303	Diacetamide		/	Unkown
HY-W722245	Pyochelin		/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Mus musculus	FES	MGD	MGI:95514
Bos taurus	FES	VGNC	VGNC:28954
Macaca mulatta	FES	VGNC	VGNC:72637
Rattus norvegicus	FES	RGD	RGD:1564385
Felis catus	FES	VGNC	VGNC:62232
Canis familiaris	FES	VGNC	VGNC:40825
Others	FES	NCBI